R.I. — CVS Health will exit its core infusion services business in the coming months and plans to either close or sell 29 related pharmacies. The company stopped taking new patients seeking ...

With rumors swirling about CVS Health's (NYSE ... help to clarify whether this stock is more likely to be a buy or a sell in the near future. Let's dive in and see. In the past five years ...

The new voicemail that was added 4-6 weeks back is totally unacceptable and CVS should be embarrassed of themselves. It’s a horrendous disease that came in and negatively infected the system ...

CVS also reported its quarterly results today, with revenue exceeding but earnings missing the street estimates.

Suddenly, this girl for no reason spray me with pepper spray ... to fully vet all of the facts in the proper forum, which does not embellish or exaggerate the claims, especially where the ...

people and events that are shaping the criminal justice conversation. The Marshall Project does not endorse the viewpoints or vouch for the accuracy of reports other than its own.

CVS's stock rose to $64 per share on the news of the breakup late Monday after trading down 12% in the past year. It was ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

CVS). Cramer said he’s “concerned” about the company “I do not like stocks that sell 7 times earnings and have a 4.7% yield.

A $20 peppermint spray has kept my abode mouse-free for well over a year. 14 Cleaning Tools That Will Make You Excited to Wash up See at Cnet Here are the various methods I used for getting rid ...

Arista Networks is a buy with a strong beat-and-raise quarter expected. CVS Health is a sell with declining profitability and weak guidance on deck. Looking for more actionable trade ideas?